Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA-associated enzymes represent a broad and diverse class of proteins that interact with and modify DNA to facilitate essential cellular processes such as replication, transcription, and repair. This category includes critical therapeutic targets such as DNA topoisomerases, which manage DNA supercoiling; DNA polymerases, responsible for synthesizing new DNA strands; and PARP enzymes, involved in DNA damage response. Many potent anticancer and antimicrobial agents function by inhibiting these enzymes or trapping them on DNA, creating lethal lesions that trigger apoptosis. Due to their fundamental role in cell proliferation, these enzymes are primary targets in oncology, though their systemic inhibition often leads to significant side effects like bone marrow suppression. The term itself is a functional descriptor rather than a specific molecular entity, encompassing various families with distinct structures and mechanisms.
Inhibition of DNA-related catalytic activities, including strand cleavage/re-ligation (topoisomerases), nucleotide polymerization (polymerases), or base excision (repair enzymes), often leading to DNA damage and cell death.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-associated enzyme.